

| Dosage | Package | Price per Dose | Price | |
|---|---|---|---|---|
| 100mg | 360 pills | C$1.10 | C$440.23 C$396.20 Best Price | |
| 100mg | 180 pills | C$1.20 | C$239.72 C$215.75 | |
| 100mg | 120 pills | C$1.27 | C$169.97 C$152.98 | |
| 100mg | 90 pills | C$1.39 | C$139.46 C$125.52 | |
| 100mg | 60 pills | C$1.51 | C$100.23 C$90.21 | |
| 100mg | 30 pills | C$1.77 | C$58.82 C$52.94 | |
| 200mg | 360 pills | C$1.10 | C$440.23 C$396.20 | |
| 200mg | 180 pills | C$1.20 | C$239.72 C$215.75 | |
| 200mg | 120 pills | C$1.27 | C$169.97 C$152.98 | |
| 200mg | 90 pills | C$1.39 | C$139.46 C$125.52 | |
| 200mg | 60 pills | C$1.71 | C$113.31 C$101.98 | |
| 200mg | 30 pills | C$1.82 | C$61.00 C$54.90 | |
| 400mg | 360 pills | C$1.75 | C$697.40 C$627.66 Popular | |
| 400mg | 180 pills | C$1.80 | C$361.77 C$325.59 | |
| 400mg | 120 pills | C$1.94 | C$259.33 C$233.40 | |
| 400mg | 90 pills | C$2.10 | C$209.20 C$188.28 | |
| 400mg | 60 pills | C$2.26 | C$150.36 C$135.32 | |
| 400mg | 30 pills | C$2.41 | C$80.62 C$72.56 |
Disclaimer: This information describes Tegretol (carbamazepine) and safety considerations in Canada. It is not a substitute for medical advice; consult a healthcare professional for personal guidance.
Trigeminal neuralgia is characterized by brief, intense facial pain in the distribution of the trigeminal nerve, often described as electric shocks. Anticonvulsants such as carbamazepine are frequently effective for reducing the frequency and severity of these attacks.
Carbamazepine is a well-established anticonvulsant used in the management of focal seizures and in the treatment of trigeminal neuralgia. It modulates nerve excitability and helps stabilize abnormal electrical activity in the brain and cranial nerves. The medication has been available for several decades and remains a common option in many treatment plans employed in Canada.
In Canada, Tegretol may be prescribed by physicians and may require a prescription depending on local rules. The information presented here reflects typical safety considerations for adults and children who may be prescribed carbamazepine by a Canadian health professional. Individual decisions depend on medical history, coexisting conditions, and concurrent therapies.
The following sections emphasize safety, monitoring, and practical use to support informed discussions with a pharmacist or prescriber. If any statement raises questions, check the official patient information leaflet or consult a healthcare professional.
Carbamazepine should not be used in individuals with known hypersensitivity to carbamazepine or to related polyether compounds. A prior severe allergic reaction necessitates avoidance unless advised otherwise by a specialist.
Concomitant use of monoamine oxidase inhibitors (MAOIs) within the preceding two weeks is a contraindication. The combination can lead to dangerous rises in blood pressure or other serious reactions, and an alternative treatment plan should be discussed with a clinician.
A history of bone marrow suppression, including agranulocytosis or aplastic anemia, raises concern for recurrent hematologic toxicity and requires careful evaluation by a healthcare professional before starting therapy.
Severe hepatic impairment or active porphyria (a group of disorders affecting the heme pathway) is a reason to avoid carbamazepine unless specifically directed by a clinician who has weighed benefits and risks. An individualized plan is essential in such cases.
Known hypersensitivity to carbamazepine or to related anticonvulsant medications should preclude use. A new or evolving rash, swelling, or breathing difficulty warrants immediate medical assessment to determine whether carbamazepine is responsible for such symptoms.
Regular monitoring is recommended to detect adverse effects early and to ensure therapeutic benefit. Blood counts, liver function, and electrolytes may be assessed at baseline and periodically during treatment as directed by a clinician.
Hyponatremia (low sodium) risk increases with age and can cause confusion, weakness, seizures, or other symptoms. Hydration, electrolyte balance, and clinical assessment are important, particularly in elderly individuals or those with conditions affecting sodium balance.
Hypertension or cardiac rhythm abnormalities may occur in rare cases; any new chest pain, palpitations, fainting, or severe dizziness warrants urgent assessment.
Mood changes, anxiety, irritability, or thoughts of self-harm must be reported promptly to a health professional. Anticonvulsant medications, including carbamazepine, have been associated with changes in mood in some patients. Urgent help should be sought if suicidal thoughts occur or worsen.
Severe skin reactions, including widespread rash, fever, or mucous membrane involvement, require urgent medical evaluation. Genetic factors may influence risk in certain populations; consult the official leaflet or a clinician for individualized risk assessment.
Side effects are commonly described by how they affect different organs or body systems. The following sections group potential effects to help recognise patterns and seek appropriate care promptly.
Drowsiness, dizziness, or lightheadedness are commonly reported when starting carbamazepine. Impairment of coordination or concentration can affect daily activities, including driving or operating machinery.
Headache and blurred vision may occur. Some individuals experience tremor or changes in balance, which usually improve with time or dose adjustments under medical supervision.
Seizure control is the aim of therapy; in some people, insufficient control may indicate suboptimal dosing or drug interactions. If seizures worsen or new seizure types appear, contact a clinician promptly.
Nausea, vomiting, abdominal discomfort, or diarrhea can occur, particularly after initiation or after dose changes. Taking tablets with meals may lessen irritation in some patients.
Loss of appetite is uncommon but may accompany other manifestations of intolerance. Persistent gastrointestinal symptoms should be discussed with a pharmacist or prescriber to determine whether dose adjustment is indicated.
Rarely, pancreatitis or significant liver injury presents with abdominal pain, persistent vomiting, fever, or jaundice. Seek urgent medical help if such signs appear.
Rash is a possible adverse effect. While most rashes are mild, some individuals may develop more serious skin reactions requiring medical assessment.
Photosensitivity (increased sensitivity to sunlight) can occur; protective clothing and sunscreen are advised for outdoor activities. Seek medical advice if a rash or blistering occurs, especially if accompanied by fever or mucous membrane involvement.
Severe dermatologic reactions, including widespread erythema multiforme or Stevens–Johnson–like manifestations, require urgent care. Any blistering or skin peeling warrants immediate medical attention.
Carbamazepine may cause changes in blood cell counts, including reductions in white blood cells or platelets. Routine blood testing helps detect such changes early.
Fever, sore throat, easy bruising, or unusual bleeding should prompt a laboratory check and clinical evaluation for potential hematologic effects.
Hypersensitivity reactions involving the skin, liver, or other organs can occur and may advise discontinuation of therapy if suspected.
Liver enzyme elevations may be detected with routine laboratory tests. Most changes are monitored and do not cause symptoms, but liver injury can rarely occur.
Carbamazepine interacts with several enzymes in the liver, potentially altering the metabolism of other medicines. Co-prescribed drugs require careful review to prevent unexpected effects.
Fluid and electrolyte balance may be influenced; hyponatremia is discussed in the warnings. Clinical monitoring may be advised for individuals with preexisting kidney or heart conditions.
Dry mouth, sweating changes, or bone or joint pain can occasionally occur. Weight changes have been reported in some patients, though long-term patterns vary among individuals.
Hair thinning or changes in hair texture are possible but usually mild. If any new or persistent symptom arises, discuss it with a pharmacist or prescriber to determine its significance.
Interactions may alter the effectiveness or safety of carbamazepine. A thorough list of all medicines, supplements, and more is important when carbamazepine is prescribed. A clinician should review all concurrent therapies before starting Tegretol.
Prescribed medicines: Certain anticonvulsants, antidepressants, antipsychotics, antibiotics, and antifungal agents can change carbamazepine levels or risk of adverse effects. Dose adjustments or monitoring may be required under medical supervision.
Over-the-counter medicines and supplements: Some products can interact with carbamazepine. Provision of the full list to a pharmacist is recommended to prevent unintended interactions.
Food and alcohol: Some foods, beverages, and alcohol can influence the metabolism of carbamazepine or exacerbate side effects such as drowsiness. In general, alcohol should be discussed with a prescriber and used with caution during treatment.
Enzyme inducers or inhibitors may alter carbamazepine blood levels. Examples of potential interactions include other seizure medicines, certain antibiotics, antifungal agents, and some antivirals. Clinical monitoring is typically advised when changes occur.
Medications that can affect heart rhythm or sodium balance may be of particular concern, necessitating closer observation and possible dose adjustments by a clinician.
Oral contraceptives and some hormone therapies can be less effective when taken with carbamazepine. Alternative or additional contraception should be discussed with a prescriber.
St. John’s wort (Hypericum perforatum) and some herbal preparations may reduce carbamazepine levels; the combination is generally discouraged without medical advice.
Antacids, certain calcium supplements, or magnesium-containing products can influence the absorption of carbamazepine if taken simultaneously. Spacing administration times may be advised.
Non-prescription sedatives or sleep aids can increase drowsiness or dizziness when used with carbamazepine. Review options with a pharmacist before use.
Alcohol can potentiate sedation and dizziness and may affect judgment or coordination. Limiting or avoiding alcohol is often advised during therapy, depending on the clinical scenario.
Grapefruit juice and some other fruit juices can interact with drug metabolism pathways. The effect varies between individuals and should be discussed with a clinician.
Food intake can influence absorption of certain formulations. Follow the instruction provided with the specific product and consult a pharmacist if questions arise.
Pregnancy: Carbamazepine may pose risks to a developing fetus. The decision to use carbamazepine during pregnancy requires careful assessment of potential benefits and risks. Use of effective contraception should be discussed with a clinician when pregnant status is not intended or uncertain.
Breastfeeding: Carbamazepine passes into breast milk. If the caregiver is breastfeeding, consult a clinician regarding possible effects on the infant and whether adjustment of therapy is required.
Elderly: Older adults may be more susceptible to hyponatremia, dizziness, and falls, as well as interactions with other medications. Dosing and monitoring strategies may be adjusted accordingly by a clinician.
Children: Pediatric patients may require different dosing considerations and monitoring. The risk of skin reactions and other adverse effects warrants close supervision by a healthcare professional during growth and development stages.
General guidance: In all populations, a careful review of concomitant illnesses, concomitant therapies, and individual risk factors is essential to optimize safety and efficacy under professional supervision. If there is uncertainty, consult the official patient information leaflet or a healthcare professional for guidance.
Take exactly as prescribed by a clinician. Do not change the dose or frequency without professional guidance, and do not stop abruptly unless advised by a clinician, to avoid withdrawal seizures or symptom recurrence.
Administration: Tablets are available in different formulations. Swallow tablets whole with water. Some formulations may be intended to be taken with meals to lessen stomach upset and improve tolerability.
Storage and handling: Store at room temperature, away from moisture and heat. Keep medications out of reach of children and ensure safety packaging is preserved. Check the expiry date before use and discard any expired product through appropriate channels.
Adherence and monitoring: Maintain regular follow-up with a pharmacist or prescriber to monitor efficacy, side effects, and laboratory parameters as indicated. Report any new symptoms, especially skin changes, mood changes, confusion, weakness, or unusual bleeding.
Travel and safety: If travel involves long flights or other disruptions, plan for continued access to prescriptions and to maintain a stable supply. Do not share medications with others, and do not use someone else’s supply.
Official patient information leaflets provided with the product contain important safety, dosing, and storage information. They should be reviewed in conjunction with clinical advice.
Health Canada consumer information and provincial pharmacare resources offer general safety guidance for prescription medications, including carbamazepine. Use these resources to understand regulatory considerations and reporting requirements for adverse effects.
Pharmacy professionals and clinicians can provide patient-specific guidance on drug interactions, monitoring plans, and management of side effects. Seek professional advice for personalized safety counsel.
When in doubt, consult a healthcare professional about any aspect of carbamazepine therapy, including potential interactions, pregnancy considerations, and monitoring needs. The goal is to maintain safety while achieving therapeutic benefit.
Safety-focused information frequently concerns how to recognise urgent problems, when to seek urgent care, and how interactions and monitoring affect daily life. The following questions and answers are intended to aid understanding and planning. For any uncertainty, contact a pharmacist or prescriber.
Alcohol can increase sedation and dizziness and may worsen coordination difficulties. It is generally advisable to limit or avoid alcohol while on therapy, depending on the clinical situation and physician advice.
If a dose is missed, consult the patient information leaflet or a pharmacist for guidance. Do not double the next dose without professional instruction, as this can raise the risk of adverse effects or reduced seizure control.
Drowsiness, dizziness, and slowed reaction time may occur, especially after starting treatment or adjusting the dose. It is prudent to assess individual response and refrain from driving or operating heavy machinery if such effects are experienced.
Carbamazepine can affect fetal development and may be present in breast milk. Discuss pregnancy plans or breastfeeding with a clinician to weigh benefits and risks and to consider alternatives if necessary.
Blood tests are commonly used to monitor blood counts, liver function, and electrolyte levels during treatment. The exact testing schedule is determined by the prescriber based on individual risk factors and response to therapy.
Carbamazepine can reduce the effectiveness of some hormonal contraceptives. A clinician may recommend an alternative method or additional precautions, depending on the contraceptive method chosen.
Any new rash, fever, blistering, or skin peeling should prompt immediate medical evaluation, as these can be signs of serious hypersensitivity or skin reaction requiring treatment modification.
Over-the-counter products, including supplements, can interact with carbamazepine. Consult a pharmacist before taking any new non-prescription medication, vitamins, or herbal products.
Acute infections or illnesses can influence drug metabolism and safety. Seek medical advice if fever, malaise, or reduced appetite occurs while taking carbamazepine, particularly if accompanied by other symptoms.
Response times vary; some patients notice improvement within days to weeks, while others may require longer to achieve full benefit. Do not adjust therapy without professional input, even if symptoms improve.
Warning signs include persistent or worsening seizures, new severe rash, chest pain, confusion, weakness, vision changes, or pronounced mood changes. Seek medical review promptly if such signs occur.
Genetic differences may affect the risk of serious skin reactions in certain populations. A clinician can assess individual risk and discuss monitoring plans based on ancestry and history. Check the official leaflet or ask a clinician for more information.
14–21 days. Free from C$280.21 .
5–9 days. C$42.03
−10% when paying with cryptocurrency.
−10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.
